Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis

Journal of International Medical Research

Volumn 36, Issue 4, 2008, Pages 830-836

  Han, J L ^a   Ding, R Y ^a   Zhao, L ^a   Ren, Z ^a   Jiang, Xue Jun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Cytokines; Galectin 3; Mice; Peroxisome proliferator activated receptor gamma agonist; Rosiglitazone

Indexed keywords

GALECTIN 3; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INFLAMMATORY CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; DRUG POTENTIATION; GENETICS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; METABOLISM; NOSE MUCUS; RANDOMIZATION; RHINITIS;

ANIMALS; DISEASE MODELS, ANIMAL; GALECTIN 3; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; MICE; MICE, INBRED BALB C; NASAL LAVAGE FLUID; NASAL MUCOSA; PPAR GAMMA; RANDOM ALLOCATION; RHINITIS; THIAZOLIDINEDIONES;

EID: 52049109854     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600426     Document Type: Article

References (22)

1. McCusker C, Chicoine M, Hamid Q, et al: Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway disease in lower airway disease. J Allergy Clin Immunol 2002; 110: 891-898.
2. Salib RJ, Drake-Lee A, Howarth PH, et al: Allergic rhinitis: past, present and the future. Clin Otolaryngol 2003; 28: 291-303.
3. Kota BP, Huang TH, Roufogalis BD: An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51: 85-94.
4. Benayoun L, Letuve S, Druilhe A, et al: Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001; 164: 1487-1494.
5. Honda K, Marquillies P, Capron M, et al: Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol 2004; 113: 882-888.
6. Woerly G, Honda K, Loyens M, et al: Peroxisome proliferator-activated receptors alpha and gamma down-regulated allergic inflammation and eosinophil activation. J Exp Med 2003; 198: 411-421.
7. Cooper DN: Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002; 1572: 209-231.
8. Sano H, Hsu DK, Yu L, et al: Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000; 165: 2156-2164.
9. Nangia-Makker P, Honjo Y, Sarvis R, et al: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156: 899-909.
10. Zuberi RI, Hsu DK, Kalyci O, et al: Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 2004; 165: 2045-2053.
11. Yamamoto K, Kawamura I, Tominaga T, et al: Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice. Clin Exp Immunol 2006; 144: 475-484.
12. Saito H, Howie K, Wattie J, et al: Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitls. Immunology 2001; 104: 226-234.
13. Lee KS, Park SJ, Hwang PH, et al: PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J 2005; 19: 1033-1035.
14. Gelman L, Fruchart JC, Auwerx J: An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell Mol Life Sci 1999; 55: 932-943.
15. Hammad H, De Heer HJ, Soullie T, et al: Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol 2004; 164: 263-267.
16. Mueller C, Weaver V, Vanden Heuvel JP, et al: Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys 2003; 418: 186-196.
17. Frigeri LG, Zuberi RI, Liu F-T: ḂP, β-galactoside-binding animal lectin, recognizes IgE receptor (FcṘI) and activates mast cells. Biochemistry 1993; 32: 7644-7649.
18. Liu F-T, Hsu DK, Zuberi RI, et al: Expression and function of galectin-3, β-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 1995. 147: 1016-1029.
19. Rao SP, Wang Z, Zuberi RI, et al: Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol 2007; 179: 7800-7807.
20. Yang R-Y, Hsu DK, Liu F-T: Expression of galectin-3 modulates T cell growth and apoptosis. Proc Natl Acad Sci USA 1996; 93: 6737-6742.
21. Akahani S, Nangia-Makker P, Inohara H, et al: Galectin-3 a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 1997; 57: 5272-5276.
22. Matarrese P, Tinari N, Semeraro ML, et al: Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 2000; 473: 311-315.